Company intelligence / Profile preview

MicroPyros BioEnerTec

Straubing, Bavaria, Germanymicropyros.de ↗

Ownership: Private
Development stage: Commercial

Overview

MicroPyros has developed and commercialized an industrial-scale biological methanation process using proprietary strains of Archaea to convert hydrogen and carbon dioxide into methane. Their technology enables the storage of renewable energy as biomethane and supports CO₂ capture/recycling. They operate Europe's first real-world biomethanation research facility ("Bio FARM") in Straubing, Germany. The company has moved from laboratory to pilot to pre-industrial to commercial scale since its founding in 2021. No clinical results as it does not develop therapeutics.

Modalities: Microbial therapy
Industry: Non-Drug Biotech

Partnerships

Pietro Fiorentini GroupHyter

Beyond the preview

Go deeper on MicroPyros BioEnerTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroPyros BioEnerTec.

Explore the full profile